When Hiromu Sakurai and colleagues from the Suzuka University of Medical Science, Japan, gave the drug orally to type I diabetic mice, they found it reduced blood glucose levels.
The drug is based on vanadium and allixin, a compound found in garlic, and its action described in an Advance Article from Metallomics available free online from today. The first issue of the new journal will be published in 2009.
In previous work they had discovered the vanadium-allixin compound treated both diabetes types when injected, but this new study shows the drug has promise as an oral treatment for the disease.
Type I diabetes (insulin dependent) is currently treated with daily injections of insulin, while type II (non-insulin dependent) is treated with drugs bearing undesirable side-effects – the authors note neither treatment is ideal.
The researchers aim to test the drug in humans in future work.
Jon Edwards | Source: alphagalileo
Further information: www.rsc.org
rsc.org/Publishing/Journals/MT/article.asp?doi=b815384c
Further Reports about: allixin > blood glucose levels > diabetes I and II > Garlic > Garlic chemical tablet > insulin dependent > Metallomics > non-insulin dependent > Vanadium
More articles from Health and Medicine:
Immune system activated in schizophrenia
20.11.2009 | Karolinska Institutet
New research helps explain why bird flu has not caused a pandemic
20.11.2009 | Imperial College London
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News